Your activity: 38 p.v.
your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com

Approach to treatment of eclamptic seizures

Approach to treatment of eclamptic seizures
It is unnecessary to routinely check for a therapeutic magnesium level as there does not appear to be a clear threshold concentration for ensuring the prevention of seizures. If the level is checked (eg, recurrent seizure), a therapeutic range of 4.8 to 8.4 mg/dL (2.0 to 3.5 mmol/L) has been recommended based on retrospective data. If magnesium toxicity is suspected (eg, loss of deep tendon reflexes), the maintenance dose should be decreased or eliminated and the magnesium level should be checked. If the serum level is >9.6 mg/dL (8 mEq/L), the infusion should be stopped and serum magnesium levels should be determined at two-hour intervals. The infusion can be restarted at a lower dose when the serum level is <8.4 mg/dL (7 mEq/L). For further information on magnesium dosing and toxicity, refer to UpToDate content on management of preeclampsia and eclampsia.

* Most initial eclamptic seizures are self-limiting (lasting 1 to 2 minutes). Supportive care is provided and medication is administered to prevent recurrence.

¶ Refer to UpToDate content on eclampsia for information on management of patients with impaired renal function.

Δ The maintenance phase is given only if a patellar reflex is present (loss of deep tendon reflexes is the first manifestation of symptomatic hypermagnesemia), respirations are greater than 12 per minute, and urine output is >100 mL over four hours.

◊ Neurology consultation and neuroimaging are indicated to rule out an intracranial lesion/stroke if (i) a seizure lasts longer than 10 minutes (ii) seizures are recurrent, (iii) a seizure occurs on "therapeutic" levels of magnesium, and/or (iv) focal neurological signs are present.
Graphic 139909 Version 3.0